Philippe Camus, M.D.
Dijon, France
MDMA: 3 ,4-methylene-dioxy-N-methylamphetamine
Left ventricular dysfunction/failure
Evidence level
low
Myocarditis (can be fulminate/fulminant)
Valvular heart disease and/or dysfunction
Pulmonary edema, cardiogenic
Pulmonary edema, noncardiogenic (NCPE)
Hematoma of/around central airway wall potentially causing UAO
Acute lung injury - ARDS
possible
Upper airway obstruction other than angioedema or hematoma